Companies

Manas AI

manasai.co

Manas AI builds AI-native drug-discovery platform to accelerate development of cancer and rare-disease medicines.

HQLondon, UK
Employees1-10
Funding$50.6M
1 active role
Healthcare AIFoundation Model ProviderB2B SaaSSeries A$50M-$200M

About

Manas AI is a seed-stage AI-native drug discovery company focused on cancer and rare diseases. It builds foundational AI models integrated with chemistry, physics, and biology to accelerate target identification, candidate generation, and preclinical development across multiple modalities, offering a platform for drug discovery to pharma/biotech researchers and monetizing via platform-based offerings and services.

Active Roles

1
Singapore/Product/147d ago

Key Investors

General Catalyst, Greylock, Mosaic Ventures, Reid Hoffman